Insects rely on juvenile hormones to regulate various physiological processes, including reproduction and molting; currently eight forms of this hormone are known. In most insects, only JH Ⅲ is synthesized. Meanwhile, aphids produce JH Ⅲ and JH Ⅲ skipped bisepoxide (JHSB). However, it remains unclear whether these compounds play distinct roles in functional regulation. In this study, we demonstrated that the tested concentrations of JH Ⅲ effectively increased the number of aphid offspring, whereas high concentrations of JHSB affected the molting process. Drip experiments showed that 10 mg/L JH Ⅲ increased the number of offspring from 39.38 ± 8.03 to 56.50 ± 13.17, whereas 10 mg/L JHSB resulted in a 60.00 %± 5.77 % failure rate in molting before adulthood. Transcriptomic analysis also revealed that in the JH Ⅲ treatment group, 9 genes and 7 pathways associated with reproduction were expressed, but not genes or pathways associated with molting. In addition, 16 genes and 9 pathways associated with molting as well as 5 genes and 4 pathways associated with reproduction were identified in the JHSB treatment group. JH Ⅲ promotes reproduction in aphids by enhancing Vg expression, whereas JHSB affects molting by inhibiting the synthesis of molting hormone-related enzymes. The results indicate that JH Ⅲ and JHSB exhibit diverse functions in Aphis craccivora. The findings have significant implications for further studies on the physiological functions of different JHs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jinsphys.2025.104791 | DOI Listing |
Pest Manag Sci
March 2025
Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Guizhou University, Guiyang, China.
Insect metamorphosis is a complex developmental process regulated by microRNAs (miRNAs) and hormonal signaling pathways. Key genes driving insect ontogenic changes are precisely modulated by miRNAs, which interact with 20-hydroxyecdysone (20E) and juvenile hormone (JH) to coordinate developmental transitions. Over the past decade, significant progress has been made in understanding miRNA biogenesis, their regulatory roles in gene expression, and their involvement in critical biological processes, including metamorphosis and chitin metabolism.
View Article and Find Full Text PDFCancer Med
March 2025
Universidad Autónoma del Estado de Morelos, Facultad de Medicina, Cuernavaca, Morelos, Mexico.
Introduction: Osteosarcoma, a highly aggressive bone cancer primarily affecting children and young adults, remains a significant challenge in clinical oncology. Metastasis stands as the primary cause of mortality in osteosarcoma patients. However, the mechanisms driving this process remain incompletely understood.
View Article and Find Full Text PDFBiol Reprod
March 2025
The Institute of Cardiovascular Sciences, School of Basic Medical Sciences; Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Mammalian sexual reproduction critically relies on the generation of haploid gametes following a specialized cell division process known as meiosis. Here, we demonstrate that N-6 Adenine-Specific DNA methyltransferase 1 (N6AMT1) plays a crucial role in the progression of meiosis during spermatogenesis, as follows. N6AMT1 was expressed in germ cells throughout the entire process of spermatogenesis, with a peak in mRNA levels in spermatocytes at the prophase I stage of meiosis.
View Article and Find Full Text PDFHistol Histopathol
February 2025
Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
Canonical and non-canonical Wnt signaling pathways are well-characterized regulators of retinal development. Wnt signaling also promotes neuroprotection and regeneration in adult tissues, including retinal ganglion cell (RGC) survival and axonal regrowth after optic nerve injury. However, it is unknown whether Wnt-dependent neuroprotection after injury in the adult CNS is associated with altered expression of developmental genes.
View Article and Find Full Text PDFHaematologica
March 2025
Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra.
Continuous treatment with ibrutinib not only exerts tumor control but also enhances T cell function in patients with chronic lymphocytic leukemia (CLL). We conducted longitudinal multi-omics analyses in samples from CLL patients receiving ibrutinib upfront to identify potential adaptive mechanisms to Bruton tyrosine kinase (BTK) inhibition during the first 12 months of continuous therapy. We found that ibrutinib induced a decrease in the expression of exhaustion markers and the proportion of Tregs and Tfh cells normalized to levels observed in healthy donors.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!